Vestal Point Capital, LP Alnylam Pharmaceuticals, Inc. Transaction History
Vestal Point Capital, LP
- $1.21 Trillion
- Q1 2024
A detailed history of Vestal Point Capital, LP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 350,000 shares of ALNY stock, worth $52 Million. This represents 4.33% of its overall portfolio holdings.
Number of Shares
350,000
Previous 35,000
900.0%
Holding current value
$52 Million
Previous $6.7 Billion
680.78%
% of portfolio
4.33%
Previous 0.71%
Shares
2 transactions
Others Institutions Holding ALNY
# of Institutions
584Shares Held
104MCall Options Held
2.82MPut Options Held
1.75M-
Capital World Investors Los Angeles, CA12.8MShares$1.9 Billion0.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$1.78 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY9.03MShares$1.34 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA7.21MShares$1.07 Billion0.2% of portfolio
-
Baillie Gifford & CO6.62MShares$983 Million0.78% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $18.3B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...